Repligen Corporation(RGEN)Earnings, Financials & Key RatiosRepligen Corporation (RGEN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company has successfully returned to 14.8% revenue growth, the high 170.94 P/E TTM and inconsistent net margins of 4.3% suggest that the current valuation may already price in a rapid recovery.
Repligen Corporation (RGEN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Repligen Corporation (RGEN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.48vs $0.38+26.3% | $194Mvs $192M+1.1% |
| Q1 2026 | Feb 24, 2026 | $0.49vs $0.44+11.4% | $198Mvs $193M+2.6% |
| Q4 2025 | Oct 28, 2025 | $0.46vs $0.42+9.5% | $189Mvs $192M-1.8% |
| Q3 2025 | Jul 29, 2025 | $0.37vs $0.40-7.5% | $182Mvs $182M+0.3% |
Recent stock market news and headlines for Repligen Corporation (RGEN)
On June 25, 2026, Repligen Corp (RGEN) shares rose 4.9% to a current price of $145.23. The stock has experienced a 52-week range between $100.99 and $175.77, in
On June 22, 2026, Repligen Corp (RGEN) shares fell 4.1% today, bringing the current price to $126.67. The stock has seen a 52-week range of $100.99 to $175.77,
Key metrics vs top competitors for Repligen Corporation (RGEN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $139.83 | $7.89B | 162.59 | 16.36% | 6.62% | 2.4% | — | |
| $17.48 | $1.65B | -1.62 | 1% | -16.5% | -79.12% | — | |
| $281.27 | $40.28B | -185.05 | 35.9% | -9.05% | -15.13% | — | |
| $25.37 | $1.17B | -20.80 | 3.55% | -29.86% | -10.69% | — | |
| $58.25 | $8.87B | -388.33 | 2.08% | -0.34% | -0.5% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — |
Repligen Corporation (RGEN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Repligen Corporation (RGEN) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Feb 24, 2026·SEC
Jan 6, 2026·SEC
Get notified when RGEN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Repligen Corporation (RGEN) stock FAQ — growth, dividends, profitability & financials explained
Repligen Corporation (RGEN) reported $763.3M in revenue for fiscal year 2025. This represents a 6903% increase from $10.9M in 1996.
Repligen Corporation (RGEN) grew revenue by 16.4% over the past year. This is strong growth.
Yes, Repligen Corporation (RGEN) is profitable, generating $51.4M in net income for fiscal year 2025 (6.6% net margin).
Repligen Corporation (RGEN) has a return on equity (ROE) of 2.4%. This is below average, suggesting room for improvement.
Repligen Corporation (RGEN) generated $104.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
